Stearic Acid Lowers Cholesterol via Bile Acid and Gut Microbiome Pathways
A crossover trial in postmenopausal women shows stearic acid uniquely alters bile acid recycling and gut microbes to reduce LDL cholesterol.
Summary
Not all saturated fats behave the same. A controlled crossover trial in mildly hypercholesterolemic postmenopausal women compared three dietary fats — stearic acid (18:0, found in beef and cocoa), palmitic acid (16:0, found in palm oil and dairy), and oleic acid (18:1, found in olive oil). Both stearic and oleic acid lowered total primary bile acids and shifted bile acid profiles compared to palmitic acid, while also increasing expression of key liver genes (FXR and SHP) that regulate cholesterol metabolism. Stearic acid additionally had unique effects on specific gut microbes and reduced secondary fecal bile acids compared to oleic acid, suggesting it alters enterohepatic bile acid recycling in a distinct way. These findings help explain why stearic acid, unlike palmitic acid, does not raise LDL cholesterol.
Detailed Summary
Dietary fat type profoundly influences cardiovascular risk, yet the mechanisms behind these differences remain incompletely understood. Stearic acid — a saturated fat abundant in beef, dark chocolate, and cocoa butter — has long been noted for not raising LDL cholesterol, unlike palmitic acid, another common saturated fat. This study sought to uncover the biological reasons why, focusing on bile acid metabolism, gut microbiome changes, and cholesterol absorption and synthesis.
Researchers conducted a secondary analysis of a randomized controlled crossover trial enrolling 17 mildly hypercholesterolemic postmenopausal women. Participants consumed isocaloric diets enriched in stearic acid, palmitic acid, or oleic acid for five weeks each, separated by two-week washouts. At the end of each dietary phase, gut microbiome composition, plasma and fecal bile acid profiles, cholesterol metabolism markers, and relevant gene expression were measured and analyzed using multi-omics approaches.
Both stearic and oleic acid diets reduced fasting total primary bile acids and raised non-fasting unconjugated primary bile acid concentrations compared to the palmitic acid diet. Liver expression of FXR and SHP — genes central to bile acid and cholesterol feedback regulation — was three to four times higher after stearic and oleic acid diets. Cholesterol synthesis relative to absorption was also 22–24% lower on these two diets. Uniquely, the stearic acid diet produced lower fecal secondary bile acids compared to oleic acid, and showed distinct microbial and bile acid signatures suggesting altered enterohepatic recycling.
These findings provide a mechanistic framework: stearic and oleic acids share hepatic regulatory pathways that reduce cholesterol, while stearic acid additionally modulates gut-liver bile acid crosstalk in ways oleic acid does not. For clinicians and health-conscious individuals, this supports replacing palmitic-acid-heavy foods with stearic-acid-rich alternatives as a lipid-lowering strategy. Key caveats include the small sample size, female-only postmenopausal population, and short dietary intervention periods.
Key Findings
- Both stearic and oleic acid diets lowered fasting total primary bile acids vs. palmitic acid, linked to reduced LDL.
- FXR and SHP liver gene expression was 3–4 times higher after stearic and oleic acid diets, suppressing cholesterol synthesis.
- Cholesterol synthesis-to-absorption ratio was 22–24% lower on stearic and oleic acid diets compared to palmitic acid.
- Stearic acid uniquely reduced fecal secondary bile acids vs. oleic acid, suggesting distinct gut-liver bile acid recycling.
- Multi-omics analysis revealed moderate-to-strong correlations (r = 0.43–0.72) linking gut microbes, bile acids, and lipid profiles.
Methodology
Secondary analysis of a randomized controlled crossover trial in 17 mildly hypercholesterolemic postmenopausal women consuming isocaloric diets enriched in stearic, palmitic, or oleic acid for five weeks each with two-week washouts. Gut microbiome, plasma and fecal bile acids, cholesterol markers, and gene expression were assessed at the end of each dietary phase using mixed-effects and multivariate models.
Study Limitations
The sample size was small (n=17), limiting statistical power and generalizability. The population was restricted to mildly hypercholesterolemic postmenopausal women, so findings may not apply to men or younger women. The summary is based on the abstract only, as the full text was not available; detailed dietary compositions and full microbiome data could not be reviewed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: